LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Strona główna・Stock List・Verve Therapeutics Inc

Search

Verve Therapeutics Inc

Closed

5.63 2.36

Overview

Share price change

24h

Current

Min

5.61

Max

5.73

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+284.27 upside

Dividends
By Dow Jones
Next Earnings	7 lis 2024

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

4.94 / 6.08 Support & Resistance

Verve Therapeutics Inc Chart

Related News

29 lis 2023, 11:32 UTC

Major Market Movers

Verve Therapeutics Shares Tumble Premarket After Stock Sales

31 paź 2023, 10:44 UTC

Acquisitions, Mergers, Takeovers

Beam Therapeutics to Sell Rights in Verve Licensing Deal to Lilly for $250 Million Upfront

29 lis 2023, 03:45 UTC

Acquisitions, Mergers, Takeovers

Verve Offering, Placement to Close on December 1 >VERV

29 lis 2023, 03:45 UTC

Acquisitions, Mergers, Takeovers

Verve: Jefferies, Guggenheim Securities Among Managers for Offering >VERV

29 lis 2023, 03:45 UTC

Acquisitions, Mergers, Takeovers

Verve: Aggregate Proceeds From Offering, Private Placement Seen at $148.0M >VERV

29 lis 2023, 03:44 UTC

Acquisitions, Mergers, Takeovers

Verve to Sell 2,296,317 Shrs to Eli Lilly for Gross Proceeds of About $23.0M >VERV

31 paź 2023, 10:29 UTC

Acquisitions, Mergers, Takeovers

Beam Therapeutics to Sell Rights in Verve Licensing Deal to Lilly for $250M Upfront

Peer Comparison

Price change

Verve Therapeutics Inc Forecast

Price Target

By TipRanks

284.27% upside

12 Months Forecast

Average 21.25 USD 284.27%

High 29 USD

Low 15 USD

Based on 4 Wall Street analysts offering 12 month price targets forVerve Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

4 ratings

4

Buy

0

Hold

0

Sell

Based on 4 analysts giving stock ratings to Verve Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

4.94 / 6.08Support & Resistance

Recent bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

There are no events.

Other stocks from the sector

LLY

Eli Lilly and Co.

902.74

UNH

UnitedHealth Group Inc

596.8

NVO

Novo Nordisk A-S

131.05

JNJ

Johnson and Johnson

164.37

ABBV

AbbVie Inc

193.18